Physician profile
Mobeen A Shirazi
NPI 1326233081
$5,914.96
in general payments reported to CMS, 2019-2025
25 companies · $1,364 in 2025
The $1,364 reported for 2025 was more than what 90% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $533 · 2021: $1,051 · 2022: $370 · 2023: $494 · 2024: $1,452 · 2025: $1,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,254 · Education: $56.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,253.76 |
| Education | $56.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $1,468.50 | 2019-2025 | |
| Neurent Medical Limited | $724.01 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Genzyme Corporation | $524.57 | 2019-2025 | |
| Stryker Corporation | $521.94 | 2020-2025 | Scopis Ent |
| Medtronic, INC. | $371.71 | 2023-2025 | Propel, Stealthstation S8 Platform, Nuvent |
| Acclarent, INC | $334.88 | 2019-2023 | Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $317.74 | 2020-2025 | Dupixent |
| Intersect Ent, INC. | $317.67 | 2019-2021 | |
| Glaxosmithkline, LLC. | $287.90 | 2019-2025 | Nucala, Trelegy Ellipta |
| Aerin Medical INC. | $223.85 | 2019-2025 | |
| Allergan, INC. | $177.26 | 2019-2021 | |
| Medtronic USA, INC. | $123.24 | 2019 | |
| Integra Lifesciences Corporation | $100.72 | 2021-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Medical Device Business Services, INC. | $96.44 | 2022 | |
| Inspire Medical Systems, INC. | $84.94 | 2024 | Inspire |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $56.99 | 2025 | |
| Amgen INC. | $28.42 | 2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $27.01 | 2025 | Xhance |
| Hologic Sales and Service, LLC | $25.00 | 2024 | Coolseal Generator |
| Arrinex, INC. | $23.56 | 2019 | |
| Kerecis Limited | $18.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Astrazeneca Pharmaceuticals Lp | $17.36 | 2025 | Tezspire |
| Abbvie INC. | $17.27 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $14.52 | 2022 | |
| Alk-Abello, INC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mobeen Shirazi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.